Clinical Senate Council

Consultant Hepatobiliary and Pancreatic Surgeon at University Hospitals of Leicester NHS Trust & Professor of Hepatobiliary and Pancreatic Surgery, University of Leicester, Clinical Senate Chair

Ashley graduated with MB, ChB from Sheffield University in 1977, obtained his FRCS in 1982 and his MD (Sheffield) in 1985. He was a Wellcome Research Fellow in Oxford from 1983-85, and from 1990-92 worked in Switzerland with Professor Blumgart, Paris with Professor Bismuth and Hannover with Professor Pichlmayer. Since 1994 he has been a consultant hepatobiliary and pancreatic surgeon at the University Hospitals of Leicester NHS Trust. He is the chief investigator and responsible for all research supervision and collaboration with external centres (national and international). He is also the lead clinician responsible for “sense checking” initiatives for service improvement and delivery. His main clinical and research interests relate to the metabolism and anti-cancer properties of intravenous lipid emulsions, the treatment of colorectal metastases and pancreatic adenocarcinoma and islet cell autotransplantation following total pancreatectomy for chronic pancreatitis. He has investigated ablative techniques for the treatment of colorectal metastases and the anti-inflammatory and anti-cancer effect of infusions of lipid emulsions containing omega-3 fatty acids. He has the largest European experience of pancreatectomy followed by islet cell auto-transplantation for chronic pancreatitis and is at present investigating the potential clinical applications of pancreatic ductal cells (intermediate cells). His interest in lipids has recently resulted in trials in acute pancreatitis, sepsis in the intensive care setting, colorectal liver metastases and pancreatic cancer.